Celltrion Inc
KRX:068270
Celltrion Inc
Cash from Financing Activities
Celltrion Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Celltrion Inc
KRX:068270
|
Cash from Financing Activities
-₩385.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
SK Bioscience Co Ltd
KRX:302440
|
Cash from Financing Activities
-₩89.6B
|
CAGR 3-Years
-288%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Green Cross Corp
KRX:006280
|
Cash from Financing Activities
₩100.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Cash from Financing Activities
-₩187.1B
|
CAGR 3-Years
-367%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Cash from Financing Activities
-₩26B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Cash from Financing Activities
₩1.7B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
See Also
What is Celltrion Inc's Cash from Financing Activities?
Cash from Financing Activities
-385.1B
KRW
Based on the financial report for Dec 31, 2023, Celltrion Inc's Cash from Financing Activities amounts to -385.1B KRW.
What is Celltrion Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-14%
Over the last year, the Cash from Financing Activities growth was -10%.